DiaSorin has announced the signing of an agreement with Unifarma and Alliance Healthcare for the distribution and sale in Italian pharmacies of the Point-Of-Care (POC) Liaison IQ immunodiagnostic platform and the first two tests available on the platform, the Liaison Quick Detect Covid TrimericS Ab and the Liaison Quick Detect Covid Ag which use lateral flow technology.
The Liaison Quick Detect Covid TrimericS Ab, in particular, is able to detect in 10 minutes the presence of specific antibodies against the Sars-CoV-2 Spike protein in capillary blood samples taken with lancing devices and is therefore a useful tool for determine whether a patient has developed an adaptive immune response against SARS-CoV-2 following the infection or vaccine.
The Liaison Quick Detect Covid Ag is instead able to identify, through nasal or nasopharyngeal swabs, the Sars-CoV-2 antigen and therefore the Covid-19 positive individuals. The agreement with Alliance Healthcare Italia, the Walgreens Boots Alliance division that deals with the distribution and wholesale of pharmaceutical products in over 9,000 pharmacies throughout the country, provides that it will handle sales in all regions except for Piedmont and Valle d’Aosta, as well as some areas of Lombardy and Liguria.
In fact, according to the agreement signed by DiaSorin, these areas are managed exclusively by Unifarma, a leading company in the distribution of drugs and parapharmaceuticals in the Northwest of Italy with a service dedicated exclusively to the over 2,600 pharmacies served daily. In Italy there are about 19,500 pharmacies, with a per capita density in line with the European average and with a capillarity that makes them an ideal place for the administration of diagnostic tests for the diagnosis of Covid-19 and for monitoring the effectiveness of the vaccination schedule and population screening.
“The partnership with Unifarma and Alliance Healthcare makes it even more accessible and simple to carry out quality tests for Covid-19 quickly, through the use of the Liaison IQ, an innovative, fast and reliable tool capable of guaranteeing the traceability of the sample. , identified by a unique barcode “, commented Carlo Rosa, CEO of the DiaSorin group, whose stock on the stock market this morning rose by 0.29% to 139.40 euros. For Intesa Sanpaolo analysts (rating add and target price under review on the share) these additional tests will also be developed thanks to the partnership with Lumos in order to implement the group’s medium-term strategy in Point-of-Care diagnostics. (All rights reserved)